{
    "symbol": "SMMT",
    "quarter": 4,
    "year": 2022,
    "date": "2023-03-10 18:43:02",
    "content": " Operationally, as we build upon the excellent foundation laid by Akeso and the deal we have consummated, we have begun to and are executing upon a number of different areas, including the work to begin clinical trials with different trial sites and vendors readying clinical drug supply for trials in our territory, preparing to expand our supply chain channels long term with respect to having the opportunity to obtain clinical and commercial supply from multiple sources as well as appropriately hiring in support of the scale-up and expansion needed to be a significant player in the late-stage bispecific oncology space."
}